3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Renal Cell
84
Kidney Neoplasms
22
Prostatic Neoplasms
14
Neoplasm Metastasis
10
Neoplasms
9
Urinary Bladder Neoplasms
8
Carcinoma, Hepatocellular
5
Liver Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Breast Neoplasms
4
Pancreatic Neoplasms
3
Melanoma
3
Colorectal Neoplasms
3
Carcinoma
3
Urethral Neoplasms
2
Sarcoma
2
Multiple Myeloma
2
Hematologic Neoplasms
2
Glioblastoma
2
Financial Stress
2
Wilms Tumor
1
Ureteral Neoplasms
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Thrombocytosis
1
Testicular Neoplasms
1
Stomach Neoplasms
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms, Germ Cell and Embryonal
1
Interventions
Etoposide
30
Carboplatin
30
Cisplatin
23
Ifosfamide
22
Filgrastim
22
Paclitaxel
18
Peripheral Blood Stem Cell Transplantation
16
Bleomycin
13
Cyclophosphamide
11
Radiotherapy
8
Thiotepa
7
Magnetic Resonance Spectroscopy
6
Gemcitabine
6
pegfilgrastim
5
Therapeutics
5
Polymerase Chain Reaction
5
Melphalan
5
Granulocyte Colony-Stimulating Factor
5
Flow Cytometry
5
Busulfan
5
etoposide phosphate
4
Temozolomide
4
Psychiatric Rehabilitation
4
Oxaliplatin
4
Dexamethasone
4
sargramostim
3
Vinblastine
3
Taxes
3
Surveys and Questionnaires
3
Methylprednisolone
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Testicular Neoplasms
×
Sorafenib
×
Genitourinary
×
Clear all
NCT00772694
2008-10-24
GCT
Fondation Wygrajmy Zdrowie
Phase 2
Unknown
20 enrolled